Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity

Natalie M. Zahr, Kilian M. Pohl, Allison J. Kwong, Edith V. Sullivan, Adolf PfefferbaumInternational Journal of Molecular Sciences 2021 · DOI

TL;DR

This study investigated the link between inflammation markers (cytokines) and brain structure in individuals with Hepatitis C Virus (HCV) infection, with or without co-occurring HIV or Alcohol Use Disorder (AUD). They found that elevated levels of the cytokine TNFα were associated with smaller subcortical white matter volume in HCV-infected individuals, suggesting a potential role for this inflammatory marker in neurodegeneration related to viral infections.

What Problem Does This Paper Address?

Chronic infections like HCV and HIV, as well as conditions like AUD, are known to impact cognitive function and brain health. Inflammation, particularly the production of pro-inflammatory cytokines, is a common biological response to these conditions. While previous research has linked certain cytokines to organ damage and cognitive deficits, the specific relationship between systemic inflammation and brain structural integrity in the context of these co-occurring conditions remains complex and not fully understood. This paper aims to clarify this by examining how specific inflammatory markers, namely IL1β, IP10, and TNFα, relate to brain volumes in individuals with HCV, with or without HIV and/or AUD. Understanding these relationships is crucial for developing targeted interventions to protect brain health in these vulnerable populations.

Methods

This was an observational, cross-sectional study. The researchers collected blood samples from participants to quantify the levels of three soluble proteins (cytokines): Interleukin-1 beta (IL1β), Interferon gamma-induced Protein 10 (IP10), and Tumor Necrosis Factor alpha (TNFα). They also used structural Magnetic Resonance Imaging (MRI) to measure the volumes of specific brain regions, focusing on the frontal cortex, subcortical white matter, caudate, putamen, and pallidum. Statistical analyses, including ANOVA and Spearman's rank correlation, were employed to assess differences in cytokine levels across diagnostic groups and to explore relationships between cytokine levels and brain volumes. A path analysis was also conducted to model the complex relationships between identified factors, soluble proteins, and subcortical white matter volume.

Datasets

The study utilized data from 321 participants, categorized into four groups:

  • Healthy Controls (n=86)
  • Individuals with Alcohol Use Disorder (AUD) (n=132)
  • Individuals with Human Immunodeficiency Virus (HIV) (n=54)
  • Individuals with both AUD and HIV (AUD+HIV) (n=49)

Within these groups, participants were also categorized based on their Hepatitis C Virus (HCV) serostatus.

Key Insights and Ideas

  • TNFα as a potential neurotoxic marker: The most striking finding is the specific association between elevated peripheral TNFα levels and reduced subcortical white matter volume in HCV-infected individuals. This suggests TNFα might play a direct role in damaging white matter in the brain, independent of other co-occurring conditions.
  • IL1β as a general indicator of illness: Lower levels of IL1β were observed across all patient groups (AUD, HIV, AUD+HIV) compared to healthy controls. This suggests IL1β might be a more general marker of systemic illness or immune dysregulation in these conditions, rather than being specific to viral infection or AUD.
  • IP10 and TNFα elevation linked to viral infection: Higher levels of IP10 and TNFα were specifically observed in individuals with HIV and those with HCV, reinforcing their role as markers associated with viral infections.
  • Comorbidity complexity: While the study aimed to disentangle the effects of AUD, HIV, and HCV, the findings highlight that TNFα's impact on brain structure is primarily linked to the presence of viral infection (HCV or HIV), rather than AUD alone.

Key Results

  • IL1β: Was significantly lower in AUD, HIV, and AUD+HIV groups compared to controls (p < 0.0001).
  • IP10 and TNFα: Were significantly higher in HIV and AUD+HIV groups compared to controls (p < 0.0001).
  • TNFα and Subcortical White Matter Volume: A significant negative correlation was found between higher peripheral TNFα levels and smaller subcortical white matter volume in HCV-infected individuals (ρ = -0.24, p = 0.0095). This relationship was even stronger in a subset of only HCV-seropositive individuals (ρ = -0.36, p = 0.006).
  • Other Cytokines and Brain Regions: No significant correlations were found between IL1β or IP10 and the brain regions examined.

Limitations and Future Work

The authors acknowledge that this is a cross-sectional study, which limits the ability to establish causality. They suggest that longitudinal studies are needed to confirm whether elevated TNFα levels precede or cause white matter volume reduction. Furthermore, the study did not include a patient population with active HCV infection without comorbidity to definitively test the hypothesis that elevated TNFα levels would correlate with diminished brain integrity in this specific context. Future research could also explore the mechanisms by which TNFα might influence white matter integrity and investigate potential therapeutic targets to mitigate these effects.

Summary updated

Abstract

Classical inflammation in response to bacterial, parasitic, or viral infections such as HIV includes local recruitment of neutrophils and macrophages and the production of proinflammatory cytokines and chemokines. Proposed biomarkers of organ integrity in Alcohol Use Disorders (AUD) include elevations in peripheral plasma levels of proinflammatory proteins. In testing this proposal, previous work included a group of human immunodeficiency virus (HIV)-infected individuals as positive controls and identified elevations in the soluble proteins TNFα and IP10; these cytokines were only elevated in AUD individuals seropositive for hepatitis C infection (HCV). The current observational, cross-sectional study evaluated whether higher levels of these proinflammatory cytokines would be associated with compromised brain integrity. Soluble protein levels were quantified in 86 healthy controls, 132 individuals with AUD, 54 individuals seropositive for HIV, and 49 individuals with AUD and HIV. Among the patient groups, HCV was present in 24 of the individuals with AUD, 13 individuals with HIV, and 20 of the individuals in the comorbid AUD and HIV group. Soluble protein levels were correlated to regional brain volumes as quantified with structural magnetic resonance imaging (MRI). In addition to higher levels of TNFα and IP10 in the 2 HIV groups and the HCV-seropositive AUD group, this study identified lower levels of IL1β in the 3 patient groups relative to the control group. Only TNFα, however, showed a relationship with brain integrity: in HCV or HIV infection, higher peripheral levels of TNFα correlated with smaller subcortical white matter volume. These preliminary results highlight the privileged status of TNFα on brain integrity in the context of infection.
BibTeX
@article{zahr2021preliminary,
  author = {Natalie M. Zahr and Kilian M. Pohl and Allison J. Kwong and Edith V. Sullivan and Adolf Pfefferbaum},
  title = {{Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity}},
  journal = {International Journal of Molecular Sciences},
  year = {2021},
  doi = {10.3390/ijms22094953},
}
Figure